The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Hesperetin-Global Market Insights and Sales Trends 2024
Synopsis
Hesperetin is the 4'-methoxy derivative of eriodictyol, a flavanone. Hesperetin's 7-O-glycoside, hesperidin, is a naturally occurring flavanon-glycoside, the main flavonoid in lemons and sweet oranges. Hesperetin (and naringenin, the parent flavanone of naringin) are not found to a significant extent in Citrus spp.
The global Hesperetin market size is expected to reach US$ 177.2 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Hesperetin in various end use industries. The expanding demands from the Pharmaceutical, Cosmetic, Food and Others, are propelling Hesperetin market. Natural, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Synthesis segment is estimated at % CAGR for the next seven-year period.
According to the "Global Use of Medicines 2023" released by the IQVIA Institute, the global drug expenditure in 2022 will be approximately US$1.48 trillion (excluding costs related to COVID vaccines and therapies), and it is predicted that it will grow at a rate of 3%-6% in the next few years. In terms of regional development trends, high-income countries such as Western Europe, North America, and Japan are expected to experience slower growth in the next few years due to already high per capita usage, while growth markets such as Asia, Latin America, and Eastern Europe are expected to grow strongly. In terms of drug expenditure, China's drug expenditure in 2022 will be about 166 billion US dollars. It is expected that the expenditure on medicines will only increase in the next few years: From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines; from the perspective of national strategy, in 2016 , the State Council issued the "Healthy China 2030" Planning Outline, and "Healthy China" has risen to a national strategy; from the perspective of industry policy, it has experienced the uncertainty brought about by the initial stage of medical reform, the implementation of the centralized procurement policy and the expansion of the drug reimbursement catalog The update will gradually achieve a dynamic balance of multiple goals such as promoting innovation, stabilizing supply, and reducing the burden on the masses.
Global Use of Medicines 2023 shows that, based on net ex-factory prices, the U.S. market will spend about $62.9 billion on medicines in 2022. Overall growth slows as the Inflation Reduction Act (IRA) spends $64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years, with ex-factory discounts and rebates in drug distribution , the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hesperetin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hesperetin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hesperetin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hesperetin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hesperetin covered in this report include Tokyo Chemical Industry Co., Ltd., Otto Chemie Pvt. Ltd., Nanjing NutriHerb BioTech Co.,Ltd, Suzhou Greenway Biotech Co.,Ltd., Wuhan Hengheda Pharm Co.,Ltd., Scandinavian Formulas, Inc., BOC Sciences and Salus Nutra Inc, etc.
The global Hesperetin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Tokyo Chemical Industry Co., Ltd.
Otto Chemie Pvt. Ltd.
Nanjing NutriHerb BioTech Co.,Ltd
Suzhou Greenway Biotech Co.,Ltd.
Wuhan Hengheda Pharm Co.,Ltd.
Scandinavian Formulas, Inc.
BOC Sciences
Salus Nutra Inc
Global Hesperetin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hesperetin market, Segment by Type:
Natural
Synthesis
Global Hesperetin market, by Application
Pharmaceutical
Cosmetic
Food
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hesperetin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hesperetin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Hesperetin is the 4'-methoxy derivative of eriodictyol, a flavanone. Hesperetin's 7-O-glycoside, hesperidin, is a naturally occurring flavanon-glycoside, the main flavonoid in lemons and sweet oranges. Hesperetin (and naringenin, the parent flavanone of naringin) are not found to a significant extent in Citrus spp.
The global Hesperetin market size is expected to reach US$ 177.2 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Hesperetin in various end use industries. The expanding demands from the Pharmaceutical, Cosmetic, Food and Others, are propelling Hesperetin market. Natural, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Synthesis segment is estimated at % CAGR for the next seven-year period.
According to the "Global Use of Medicines 2023" released by the IQVIA Institute, the global drug expenditure in 2022 will be approximately US$1.48 trillion (excluding costs related to COVID vaccines and therapies), and it is predicted that it will grow at a rate of 3%-6% in the next few years. In terms of regional development trends, high-income countries such as Western Europe, North America, and Japan are expected to experience slower growth in the next few years due to already high per capita usage, while growth markets such as Asia, Latin America, and Eastern Europe are expected to grow strongly. In terms of drug expenditure, China's drug expenditure in 2022 will be about 166 billion US dollars. It is expected that the expenditure on medicines will only increase in the next few years: From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines; from the perspective of national strategy, in 2016 , the State Council issued the "Healthy China 2030" Planning Outline, and "Healthy China" has risen to a national strategy; from the perspective of industry policy, it has experienced the uncertainty brought about by the initial stage of medical reform, the implementation of the centralized procurement policy and the expansion of the drug reimbursement catalog The update will gradually achieve a dynamic balance of multiple goals such as promoting innovation, stabilizing supply, and reducing the burden on the masses.
Global Use of Medicines 2023 shows that, based on net ex-factory prices, the U.S. market will spend about $62.9 billion on medicines in 2022. Overall growth slows as the Inflation Reduction Act (IRA) spends $64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years, with ex-factory discounts and rebates in drug distribution , the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Hesperetin, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Hesperetin market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Hesperetin market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Hesperetin sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Hesperetin covered in this report include Tokyo Chemical Industry Co., Ltd., Otto Chemie Pvt. Ltd., Nanjing NutriHerb BioTech Co.,Ltd, Suzhou Greenway Biotech Co.,Ltd., Wuhan Hengheda Pharm Co.,Ltd., Scandinavian Formulas, Inc., BOC Sciences and Salus Nutra Inc, etc.
The global Hesperetin market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Tokyo Chemical Industry Co., Ltd.
Otto Chemie Pvt. Ltd.
Nanjing NutriHerb BioTech Co.,Ltd
Suzhou Greenway Biotech Co.,Ltd.
Wuhan Hengheda Pharm Co.,Ltd.
Scandinavian Formulas, Inc.
BOC Sciences
Salus Nutra Inc
Global Hesperetin market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Hesperetin market, Segment by Type:
Natural
Synthesis
Global Hesperetin market, by Application
Pharmaceutical
Cosmetic
Food
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Hesperetin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Hesperetin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Hesperetin Market Overview
1.1 Hesperetin Product Overview
1.2 Hesperetin Market Segment by Type
1.2.1 Natural
1.2.2 Synthesis
1.3 Global Hesperetin Market Size by Type
1.3.1 Global Hesperetin Market Size Overview by Type (2018-2029)
1.3.2 Global Hesperetin Historic Market Size Review by Type (2018-2023)
1.3.3 Global Hesperetin Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hesperetin Sales Breakdown by Type (2018-2023)
1.4.2 Europe Hesperetin Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Hesperetin Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Hesperetin Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Hesperetin Sales Breakdown by Type (2018-2023)
2 Global Hesperetin Market Competition by Company
2.1 Global Top Players by Hesperetin Sales (2018-2023)
2.2 Global Top Players by Hesperetin Revenue (2018-2023)
2.3 Global Top Players by Hesperetin Price (2018-2023)
2.4 Global Top Manufacturers Hesperetin Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hesperetin Market Competitive Situation and Trends
2.5.1 Hesperetin Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Hesperetin Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hesperetin as of 2022)
2.7 Date of Key Manufacturers Enter into Hesperetin Market
2.8 Key Manufacturers Hesperetin Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hesperetin Status and Outlook by Region
3.1 Global Hesperetin Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hesperetin Historic Market Size by Region
3.2.1 Global Hesperetin Sales in Volume by Region (2018-2023)
3.2.2 Global Hesperetin Sales in Value by Region (2018-2023)
3.2.3 Global Hesperetin Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Hesperetin Forecasted Market Size by Region
3.3.1 Global Hesperetin Sales in Volume by Region (2024-2029)
3.3.2 Global Hesperetin Sales in Value by Region (2024-2029)
3.3.3 Global Hesperetin Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hesperetin by Application
4.1 Hesperetin Market Segment by Application
4.1.1 Pharmaceutical
4.1.2 Cosmetic
4.1.3 Food
4.1.4 Others
4.2 Global Hesperetin Market Size by Application
4.2.1 Global Hesperetin Market Size Overview by Application (2018-2029)
4.2.2 Global Hesperetin Historic Market Size Review by Application (2018-2023)
4.2.3 Global Hesperetin Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hesperetin Sales Breakdown by Application (2018-2023)
4.3.2 Europe Hesperetin Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Hesperetin Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Hesperetin Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Hesperetin Sales Breakdown by Application (2018-2023)
5 North America Hesperetin by Country
5.1 North America Hesperetin Historic Market Size by Country
5.1.1 North America Hesperetin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hesperetin Sales in Volume by Country (2018-2023)
5.1.3 North America Hesperetin Sales in Value by Country (2018-2023)
5.2 North America Hesperetin Forecasted Market Size by Country
5.2.1 North America Hesperetin Sales in Volume by Country (2024-2029)
5.2.2 North America Hesperetin Sales in Value by Country (2024-2029)
6 Europe Hesperetin by Country
6.1 Europe Hesperetin Historic Market Size by Country
6.1.1 Europe Hesperetin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hesperetin Sales in Volume by Country (2018-2023)
6.1.3 Europe Hesperetin Sales in Value by Country (2018-2023)
6.2 Europe Hesperetin Forecasted Market Size by Country
6.2.1 Europe Hesperetin Sales in Volume by Country (2024-2029)
6.2.2 Europe Hesperetin Sales in Value by Country (2024-2029)
7 Asia-Pacific Hesperetin by Region
7.1 Asia-Pacific Hesperetin Historic Market Size by Region
7.1.1 Asia-Pacific Hesperetin Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hesperetin Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Hesperetin Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Hesperetin Forecasted Market Size by Region
7.2.1 Asia-Pacific Hesperetin Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hesperetin Sales in Value by Region (2024-2029)
8 Latin America Hesperetin by Country
8.1 Latin America Hesperetin Historic Market Size by Country
8.1.1 Latin America Hesperetin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hesperetin Sales in Volume by Country (2018-2023)
8.1.3 Latin America Hesperetin Sales in Value by Country (2018-2023)
8.2 Latin America Hesperetin Forecasted Market Size by Country
8.2.1 Latin America Hesperetin Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hesperetin Sales in Value by Country (2024-2029)
9 Middle East and Africa Hesperetin by Country
9.1 Middle East and Africa Hesperetin Historic Market Size by Country
9.1.1 Middle East and Africa Hesperetin Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hesperetin Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Hesperetin Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Hesperetin Forecasted Market Size by Country
9.2.1 Middle East and Africa Hesperetin Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hesperetin Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Tokyo Chemical Industry Co., Ltd.
10.1.1 Tokyo Chemical Industry Co., Ltd. Company Information
10.1.2 Tokyo Chemical Industry Co., Ltd. Introduction and Business Overview
10.1.3 Tokyo Chemical Industry Co., Ltd. Hesperetin Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Tokyo Chemical Industry Co., Ltd. Hesperetin Products Offered
10.1.5 Tokyo Chemical Industry Co., Ltd. Recent Development
10.2 Otto Chemie Pvt. Ltd.
10.2.1 Otto Chemie Pvt. Ltd. Company Information
10.2.2 Otto Chemie Pvt. Ltd. Introduction and Business Overview
10.2.3 Otto Chemie Pvt. Ltd. Hesperetin Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Otto Chemie Pvt. Ltd. Hesperetin Products Offered
10.2.5 Otto Chemie Pvt. Ltd. Recent Development
10.3 Nanjing NutriHerb BioTech Co.,Ltd
10.3.1 Nanjing NutriHerb BioTech Co.,Ltd Company Information
10.3.2 Nanjing NutriHerb BioTech Co.,Ltd Introduction and Business Overview
10.3.3 Nanjing NutriHerb BioTech Co.,Ltd Hesperetin Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Nanjing NutriHerb BioTech Co.,Ltd Hesperetin Products Offered
10.3.5 Nanjing NutriHerb BioTech Co.,Ltd Recent Development
10.4 Suzhou Greenway Biotech Co.,Ltd.
10.4.1 Suzhou Greenway Biotech Co.,Ltd. Company Information
10.4.2 Suzhou Greenway Biotech Co.,Ltd. Introduction and Business Overview
10.4.3 Suzhou Greenway Biotech Co.,Ltd. Hesperetin Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Suzhou Greenway Biotech Co.,Ltd. Hesperetin Products Offered
10.4.5 Suzhou Greenway Biotech Co.,Ltd. Recent Development
10.5 Wuhan Hengheda Pharm Co.,Ltd.
10.5.1 Wuhan Hengheda Pharm Co.,Ltd. Company Information
10.5.2 Wuhan Hengheda Pharm Co.,Ltd. Introduction and Business Overview
10.5.3 Wuhan Hengheda Pharm Co.,Ltd. Hesperetin Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Wuhan Hengheda Pharm Co.,Ltd. Hesperetin Products Offered
10.5.5 Wuhan Hengheda Pharm Co.,Ltd. Recent Development
10.6 Scandinavian Formulas, Inc.
10.6.1 Scandinavian Formulas, Inc. Company Information
10.6.2 Scandinavian Formulas, Inc. Introduction and Business Overview
10.6.3 Scandinavian Formulas, Inc. Hesperetin Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Scandinavian Formulas, Inc. Hesperetin Products Offered
10.6.5 Scandinavian Formulas, Inc. Recent Development
10.7 BOC Sciences
10.7.1 BOC Sciences Company Information
10.7.2 BOC Sciences Introduction and Business Overview
10.7.3 BOC Sciences Hesperetin Sales, Revenue and Gross Margin (2018-2023)
10.7.4 BOC Sciences Hesperetin Products Offered
10.7.5 BOC Sciences Recent Development
10.8 Salus Nutra Inc
10.8.1 Salus Nutra Inc Company Information
10.8.2 Salus Nutra Inc Introduction and Business Overview
10.8.3 Salus Nutra Inc Hesperetin Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Salus Nutra Inc Hesperetin Products Offered
10.8.5 Salus Nutra Inc Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hesperetin Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hesperetin Industrial Chain Analysis
11.4 Hesperetin Market Dynamics
11.4.1 Hesperetin Industry Trends
11.4.2 Hesperetin Market Drivers
11.4.3 Hesperetin Market Challenges
11.4.4 Hesperetin Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hesperetin Distributors
12.3 Hesperetin Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Chemicals Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
